Newbury Pharmaceuticals AB (SE0015244884) — research page
SE · se-cm-kg/SSME/SE0015244884 · as of 2026-11-06
Identity and listing
The issuer is Newbury Pharmaceuticals AB, listed on First North Sweden under ticker SE0015244884, with ISIN SE0015244884 and LEI 549300F7XHU3I8CWL373. Security type, segment, sector and jurisdiction are not on the record. Listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Newbury Pharmaceuticals AB | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | SE0015244884 | source · 2026-11-06 |
| ISIN | SE0015244884 | source · 2026-11-06 |
| LEI | 549300F7XHU3I8CWL373 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 21 filings on 19 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 8.0 days. The latest filing is dated 2026-10-28 and is a financial statement release, 9 days before the record date of 2026-11-06. Exchange peers on First North Sweden (325 issuers) show a median cadence gap of 11.0 days, a median of 21 filings, and a median latency of 7 days. Sector peer figures are not on the record for this market.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 21 | 8 | 9 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-28 | Financial statement release | Financial statement release | Newbury Pharmaceuticals year-end report September 2025 - August 2026 |
| 2026-10-27 | Investor News | Investor News | Newbury Pharmaceuticals Secures Generic Approval for Prukalopride Newbury |
| 2026-10-26 | Investor News | Investor News | Newbury Pharmaceuticals international receives import approvals for 19 hospital product |
| 2026-09-28 | Investor News | Investor News | Newbury Pharmaceuticals secures exclusive rights to a 40-product hospital portfolio in Iraq |
| 2026-08-17 | Investor News | Investor News | Newbury Pharmaceuticals accelerates its neuroscience ambitions with a new partnership for Guanfacine tablets |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. Auditor changes are not on the record, because the register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, because the index carries no lifecycle type map for this register yet. The halt flag is not set; the issuer is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/SE0015244884 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://mcp.se-cm-kg.ai/record/SSME/SE0015244884 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0015244884"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:69d258656e713e8b.